NEU 2.11% $12.09 neuren pharmaceuticals limited

CSL/COH/MSB

  1. MT2
    345 Posts.
    There have been some spectacular Australian success stories in the past, and we are all looking for the next one. The market for the product has to be global and extremely large. The product will need to be unique, with no major competitors. Given the successful Phase II Rett results recently announced I believe Neuren probably have the goods and the right management team in place to be able to pull this off.

    Maybe NEU will not even need to sign up a single big pharma partner with this one. Management are quite capable of manufacturing NNZ-2256 themselves and then just selling this to the big players, a bit like Coca Cola sells its syrup?

    Just picture NEU manufacturing NNZ-2256 and supplying this possible wonder drug to some of the biggest global medicine manufacturers for conditions including Traumatic Brain Injury/Concussion/Rett syndrome/Fragile X/ plus possibly all the other Autism Spectrum Disorders/ and then possibly MS/Alzheimers/ and possibly even the massive Depression market? I don’t know. But maybe this could even be taken by people of normal health just to improve the cognitive performance??? Could it be a super steroid for the brain as well as “asprin for the brain” as Dr. Glass has called it???

    One then starts to think of the major Australian cash cows in this sector such as CSL.

    Anyway, we can but dream! Why not? Early days, but CSL had early days too.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$12.09
Change
-0.260(2.11%)
Mkt cap ! $1.545B
Open High Low Value Volume
$12.20 $12.20 $12.04 $762.4K 63.02K

Buyers (Bids)

No. Vol. Price($)
4 330 $12.08
 

Sellers (Offers)

Price($) Vol. No.
$12.09 74 5
View Market Depth
Last trade - 11.25am 01/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.